Back
TG Therapeutics Quote, Financials, Valuation and Earnings
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
58
TGTX
TG Therapeutics
Last Price:
34.51
Seasonality Move:
52.51%
7 Day Trial
ALL ACCESS PASS
$
7
Access The Stock Grader Trading Tool From "The King Of Quants"
More details here...TG Therapeutics Price Quote
$34.51
+3.36 (+10.79%)
(Updated: November 21, 2024 at 5:55 PM ET)
TG Therapeutics Key Stats
Buy
58
TG Therapeutics (TGTX)
is a Buy
Day range:
$29.91 - $32.00
52-week range:
$11.86 - $36.50
Dividend yield:
0%
P/E ratio:
329.00
P/S ratio:
17.40
P/B ratio:
23.99%
Volume:
2.2M
Avg. volume:
3.6M
1-year change:
142.98%
Market cap:
$4.6B
Revenue:
$233.7M
EPS:
$-0.11
How Much Does TG Therapeutics Make?
-
How Much Are TG Therapeutics's Sales Annually?
TGTX Revenues are $233.7M -
How Much Profit Does TG Therapeutics's Make A Year?
TGTX net income is $12.7M
Is TG Therapeutics Growing As A Company?
-
What Is TG Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.49% -
What Is TG Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is -0.97%
TG Therapeutics Stock Price Performance
-
Did TG Therapeutics Stock Go Up Last Month?
TG Therapeutics share price went up by 33.63% last month -
Did TGTX's Share Price Rise Over The Last Year?
TGTX share price rose by 142.98% over the past 1 year
What Is TG Therapeutics 52-Week High & Low?
-
What Is TG Therapeutics’s 52-Week High Share Price?
TG Therapeutics has traded as high as $36.50 over the past 52 weeks -
What Is TG Therapeutics’s 52-Week Low Share Price?
TG Therapeutics has traded as low as $11.86 over the past 52 weeks
TG Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy TG Therapeutics?
-
How Much Debt Does TG Therapeutics Have?
Total long term debt quarterly is $244.2M -
How Much Cash Does TG Therapeutics Have?
Cash and short term investments quarterly total is $341M -
What Is TG Therapeutics’s Book Value Per Share?
Book value per share is 1.23
Is TG Therapeutics Cash Flow Positive?
-
What Is TGTX Cash Flow From Operations?
Cash flow from operations (TTM) is -$28.1M -
What Is TG Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $134.6M -
What Is TG Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$61.6M
TG Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
TGTX return on invested capital is -4.78% -
What Is TG Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -3.55% -
What Is TGTX Return On Equity?
ROE is a measure of profitability and is -8.4%
TG Therapeutics Earnings Date & Stock Price
-
What Is TG Therapeutics's Stock Price Today?
A single share of TGTX can be purchased today for 31.15 -
What Is TG Therapeutics’s Stock Symbol?
TG Therapeutics trades on the nasdaq under the ticker symbol: TGTX -
When Is TG Therapeutics’s Next Earnings Date?
The next quarterly earnings date for TG Therapeutics is scheduled on February 28, 2025 -
When Is TGTX's next ex-dividend date?
TG Therapeutics's next ex-dividend date is November 22, 2024 -
How To Buy TG Therapeutics Stock?
You can buy TG Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
TG Therapeutics Competitors
-
Who Are TG Therapeutics's Competitors?
Below is a list of companies who compete with TG Therapeutics or are related in some way:
TG Therapeutics Dividend Yield
-
What Is TGTX Dividend Yield?
TG Therapeutics’s dividend yield currently is 0% -
What Is TG Therapeutics’s Payout Ratio?
TG Therapeutics’s payout ratio is 0% -
When Did TG Therapeutics Last Pay A Dividend?
The latest dividend pay date is November 22, 2024 -
What Is TG Therapeutics’s Dividend Per Share?
TG Therapeutics pays a dividend of $0.00 per share
TG Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | -97.26% | -40.92% |
| Revenue: | -49.41% | 2.66% |
Analyst Recommendations
| Buy Recommendations: | 6 |
|---|---|
| Hold Recommendations: | 1 |
| Sell Recommendations: | 0 |
| Price Target: | 37.22 |
| Upside from Last Price: | 19.49% |